|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Chlamydia Trachomatis IgM ELISA | Amyloidß (1-43) (FL) ELISA Assay | Anti-Ustekinumab (Stelara®) ELISA | Dopamine ELISA Assay | GHBP ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB05034 | 27710 | TM09036 | IB89547R | E024 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme linked immunosorbent assay (ELISA) for the determination of human IgM antibodies in serum or plasma directed against Chlamydia trachomatis. For research use only, not for use in diagnostic procedures. | Sandwich enzyme-linked immune-sorbent assay (ELISA) for the determination of human Amyloid ß (1-43) in cerebrospinal fluid, brain extract of Tg mouse and cell culture supernatant. For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Enzyme Immunoassay (ELISA) for the determination of Dopamine in plasma and urine. For research use only, not for use in diagnostic procedures. | Sandwich enzyme immunoassay (ELISA) for the determination of Growth Hormone Binding Protein (GHBP) in serum and plasma. For research use only, not for use in diagnostic procedures. |
| Detection Target | Chlamydia Trachomatis IgM | Anti-Etanercept (Enbrel®) | sAPP Total | Progesterone (Free in Saliva) | IGF-1 (or SM-C) |
| Sample Type | Serum or plasma (EDTA, citrate, heparin). | Serum and plasma. | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Saliva | Serum |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A calculated cut-off value is used to interpret results of unknowns. | 2.34 to 150 pg/mL | Anti-Ustekinumab (Stelara®) | 10 to 2000 ng/mL (Urine), 4.5 to 2000 ng/mL (Plasma) | 0.05 to 4.00 ng/mL |
| Sensitivity | > 93% | 40 ng/mL | 0.06 ng/mL | 20 pg/mL | 3.4 ng/mL |
| Assay Time | 1 hour (37°C) + 30 min. (37°C) + 30 min. (37°C) = 2 hours total incubation time. | Overnight + 1 hr 30 mins (incubation) | 2 hour, 30 min. total incubation time. | 4 hrs 30 mins (incubation) | 3 hrs (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |